{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:50:46Z","timestamp":1791489046378,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Esophagogastric cancers remain among the leading causes of cancer-related mortality worldwide. Surgical resection represents the primary curative treatment strategy; however, perioperative factors may influence long-term oncological outcomes. Experimental and clinical evidence suggests that anesthetic techniques may affect tumor progression and recurrence through immunological and oncological pathways. Total intravenous anesthesia (TIVA) has been proposed to exert immunomodulatory and antitumor effects compared to volatile anesthesia (VA), although evidence remains inconclusive. This systematic review and meta-analysis aimed to evaluate the impact of TIVA versus volatile anesthesia on survival outcomes in patients undergoing esophagogastric cancer surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was conducted according to PRISMA 2020 guidelines. PubMed and Scopus were searched for studies published between 2010 and 2025 comparing TIVA with volatile anesthesia in adult patients undergoing curative surgery for esophageal or gastric cancer. The primary outcome was overall survival (OS). Secondary outcomes included recurrence-free survival (RFS), early mortality, operation time, and postoperative hospital stay. Pooled hazard ratios (HR), risk ratios (RR), and mean differences (MD) with 95% confidence intervals (CI) were calculated using random-effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen studies (3 randomized controlled trials and 10 retrospective studies) involving 264,543 patients were included. Of these, 41,977 patients received TIVA and 222,566 received volatile anesthesia. Pooled analysis of eight studies demonstrated significantly improved overall survival with TIVA (HR 0.80, 95% CI 0.69\u20130.93;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003). Subgroup analysis showed a significant survival benefit in patients undergoing gastrectomy (HR 0.74, 95% CI 0.60\u20130.91;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.004), whereas no significant difference was observed for esophagectomy (HR 0.89, 95% CI 0.73\u20131.10;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.29). TIVA was associated with non-significant trends toward improved recurrence-free survival (HR 0.91, 95% CI 0.77\u20131.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.22) and reduced early mortality (HR 0.90, 95% CI 0.77\u20131.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.17). No statistically significant differences were observed in operation time (MD\u2009\u2212\u20093.81\u00a0min, 95% CI\u2009\u2212\u200910.75 to 3.13) or hospital stay (MD\u2009\u2212\u20090.19 days, 95% CI\u2009\u2212\u20090.39 to 0.00;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.06).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TIVA may be associated with improved long-term survival outcomes compared with volatile anesthesia in patients undergoing esophagogastric cancer surgery, particularly among patients undergoing gastrectomy. Given the predominance of retrospective evidence and methodological heterogeneity, further high-quality prospective randomized studies are required to clarify the oncological impact of anesthetic techniques in upper gastrointestinal cancer surgery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00423-026-04329-3","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:18:09Z","timestamp":1791368289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival outcomes following total intravenous versus volatile anesthesia in esophagogastric cancer surgery: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"411","author":[{"given":"Efstathia","family":"Liatsou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pliakopanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Liatsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Karniadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Khodakaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Schizas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Rouvelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"3","key":"4329_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin May-Jun 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin May-Jun"},{"issue":"10","key":"4329_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S et al (2022) Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Oct 33(10):1005\u20131020. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004","journal-title":"Ann Oncol Oct"},{"issue":"10","key":"4329_CR3","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","volume":"33","author":"R Obermannov\u00e1","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A et al (2022) Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Oct 33(10):992\u20131004. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.003","journal-title":"Ann Oncol Oct"},{"issue":"4","key":"4329_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","volume":"12","author":"M Horowitz","year":"2015","unstructured":"Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol Apr 12(4):213\u2013226. https:\/\/doi.org\/10.1038\/nrclinonc.2014.224","journal-title":"Nat Rev Clin Oncol Apr"},{"issue":"9","key":"4329_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bjae.2020.04.006","volume":"20","author":"B Cusack","year":"2020","unstructured":"Cusack B, Buggy DJ (2020) Anaesthesia, analgesia, and the surgical stress response. BJA Educ Sep 20(9):321\u2013328. https:\/\/doi.org\/10.1016\/j.bjae.2020.04.006","journal-title":"BJA Educ Sep"},{"issue":"3","key":"4329_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/03009734.2014.922649","volume":"119","author":"M Enlund","year":"2014","unstructured":"Enlund M, Berglund A, Andreasson K, Cicek C, Enlund A, Bergkvist L (2014) The choice of anaesthetic\u2013sevoflurane or propofol\u2013and outcome from cancer surgery: a retrospective analysis. Ups J Med Sci Aug 119(3):251\u2013261. https:\/\/doi.org\/10.3109\/03009734.2014.922649","journal-title":"Ups J Med Sci Aug"},{"issue":"1","key":"4329_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/aln.0000000000000936","volume":"124","author":"TJ Wigmore","year":"2016","unstructured":"Wigmore TJ, Mohammed K, Jhanji S (2016) Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis. Anesthesiology Jan 124(1):69\u201379. https:\/\/doi.org\/10.1097\/aln.0000000000000936","journal-title":"Anesthesiology Jan"},{"issue":"2","key":"4329_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1177\/0310057x1404200209","volume":"42","author":"T Zhang","year":"2014","unstructured":"Zhang T, Fan Y, Liu K, Wang Y (2014) Effects of different general anaesthetic techniques on immune responses in patients undergoing surgery for tongue cancer. Anaesth Intensive Care Mar 42(2):220\u2013227. https:\/\/doi.org\/10.1177\/0310057x1404200209","journal-title":"Anaesth Intensive Care Mar"},{"issue":"5","key":"4329_CR9","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1365-2044.2010.06304.x","volume":"65","author":"XF Ren","year":"2010","unstructured":"Ren XF, Li WZ, Meng FY, Lin CF (2010) Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia May 65(5):478\u2013482. https:\/\/doi.org\/10.1111\/j.1365-2044.2010.06304.x","journal-title":"Anaesthesia May"},{"issue":"4","key":"4329_CR10","doi-asserted-by":"publisher","first-page":"612","DOI":"10.5114\/wiitm.2023.133916","volume":"18","author":"Q Yan","year":"2023","unstructured":"Yan Q, Liang H, Yin H, Ye X (2023) Anesthesia-related postoperative oncological surgical outcomes: a comparison of total intravenous anesthesia and volatile anesthesia. A meta-analysis. Wideochir Inne Tech Maloinwazyjne Dec 18(4):612\u2013624. https:\/\/doi.org\/10.5114\/wiitm.2023.133916","journal-title":"Wideochir Inne Tech Maloinwazyjne Dec"},{"key":"4329_CR11","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372","DOI":"10.1136\/bmj.n71"},{"key":"4329_CR12","doi-asserted-by":"crossref","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366","DOI":"10.1136\/bmj.l4898"},{"key":"4329_CR13","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj Oct 12 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"Bmj Oct 12"},{"key":"4329_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"20","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol Apr 20:5:13. https:\/\/doi.org\/10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol Apr"},{"issue":"5","key":"4329_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1053\/j.jvca.2012.01.015","volume":"26","author":"JJ Lee","year":"2012","unstructured":"Lee JJ, Kim GH, Kim JA et al (2012) Comparison of pulmonary morbidity using sevoflurane or propofol-remifentanil anesthesia in an Ivor Lewis operation. J Cardiothorac Vasc Anesth Oct 26(5):857\u2013862. https:\/\/doi.org\/10.1053\/j.jvca.2012.01.015","journal-title":"J Cardiothorac Vasc Anesth Oct"},{"issue":"1","key":"4329_CR16","doi-asserted-by":"publisher","first-page":"14020","DOI":"10.1038\/s41598-017-14147-9","volume":"25","author":"IJ Jun","year":"2017","unstructured":"Jun IJ, Jo JY, Kim JI et al (2017) Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study. Sci Rep Oct 25(1):14020. https:\/\/doi.org\/10.1038\/s41598-017-14147-9","journal-title":"Sci Rep Oct"},{"key":"4329_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2147\/ott.S156792","volume":"11","author":"X Zheng","year":"2018","unstructured":"Zheng X, Wang Y, Dong L et al (2018) Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. Onco Targets Ther 11:1141\u20131148. https:\/\/doi.org\/10.2147\/ott.S156792","journal-title":"Onco Targets Ther"},{"issue":"9","key":"4329_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/aas.13414","volume":"63","author":"TK Oh","year":"2019","unstructured":"Oh TK, Kim HH, Jeon YT (2019) Retrospective analysis of 1-year mortality after gastric cancer surgery: Total intravenous anesthesia versus volatile anesthesia. Acta Anaesthesiol Scand Oct 63(9):1169\u20131177. https:\/\/doi.org\/10.1111\/aas.13414","journal-title":"Acta Anaesthesiol Scand Oct"},{"issue":"4","key":"4329_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/aln.0000000000003440","volume":"1","author":"K Makito","year":"2020","unstructured":"Makito K, Matsui H, Fushimi K, Yasunaga H (2020) Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery. Anesthesiology Oct 1(4):764\u2013773. https:\/\/doi.org\/10.1097\/aln.0000000000003440","journal-title":"Anesthesiology Oct"},{"issue":"25","key":"4329_CR20","doi-asserted-by":"publisher","first-page":"e20714","DOI":"10.1097\/md.0000000000020714","volume":"19","author":"NC Huang","year":"2020","unstructured":"Huang NC, Lee MS, Lai HC et al (2020) Propofol-based total intravenous anesthesia improves survival compared to desflurane anesthesia in gastric cancer surgery: A retrospective analysis. Medicine (Baltimore) Jun 19(25):e20714. https:\/\/doi.org\/10.1097\/md.0000000000020714","journal-title":"Medicine (Baltimore) Jun"},{"issue":"1","key":"4329_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1186\/s12885-021-08946-7","volume":"10","author":"WW Wu","year":"2021","unstructured":"Wu WW, Zhang WH, Zhang WY et al (2021) The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study. BMC Cancer Nov 10(1):1193. https:\/\/doi.org\/10.1186\/s12885-021-08946-7","journal-title":"BMC Cancer Nov"},{"issue":"1","key":"4329_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/s41598-021-81012-1","volume":"15","author":"NY Kim","year":"2021","unstructured":"Kim NY, Kim KJ, Lee KY et al (2021) Effect of volatile and total intravenous anesthesia on syndecan-1 shedding after minimally invasive gastrectomy: a randomized trial. Sci Rep Jan 15(1):1511. https:\/\/doi.org\/10.1038\/s41598-021-81012-1","journal-title":"Sci Rep Jan"},{"issue":"1","key":"4329_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12871-023-02023-1","volume":"2","author":"Y Ma","year":"2023","unstructured":"Ma Y, Ren J, Chen Z et al (2023) Outcomes of intravenous and inhalation anesthesia on patients undergoing esophageal cancer surgery: a retrospective observational study. BMC Anesthesiol Mar 2(1):66. https:\/\/doi.org\/10.1186\/s12871-023-02023-1","journal-title":"BMC Anesthesiol Mar"},{"issue":"6","key":"4329_CR24","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/sla.0000000000005568","volume":"1","author":"S Yoon","year":"2023","unstructured":"Yoon S, Jung SY, Kim MS, Yoon D, Cho Y, Jeon Y (2023) Impact of Propofol-based Total Intravenous Anesthesia Versus Inhalation Anesthesia on Long-term Survival After Cancer Surgery in a Nationwide Cohort. Ann Surg Dec 1(6):1024\u20131031. https:\/\/doi.org\/10.1097\/sla.0000000000005568","journal-title":"Ann Surg Dec"},{"issue":"5","key":"4329_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.4097\/kja.22747","volume":"76","author":"TK Oh","year":"2023","unstructured":"Oh TK, Jo H, Song IA (2023) Propofol-based intravenous anesthesia is associated with improved survival outcomes after major cancer surgery: a nationwide cohort study in South Korea. Korean J Anesthesiol Oct 76(5):461\u2013470. https:\/\/doi.org\/10.4097\/kja.22747","journal-title":"Korean J Anesthesiol Oct"},{"issue":"3","key":"4329_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1213\/ane.0000000000006814","volume":"1","author":"YT Zhang","year":"2024","unstructured":"Zhang YT, Chen Y, Shang KX, Yu H, Li XF, Yu H (2024) Effect of Volatile Anesthesia Versus Intravenous Anesthesia on Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy: A Randomized Clinical Trial. Anesth Analg Sep 1(3):571\u2013580. https:\/\/doi.org\/10.1213\/ane.0000000000006814","journal-title":"Anesth Analg Sep"},{"issue":"11","key":"4329_CR27","doi-asserted-by":"publisher","first-page":"109375","DOI":"10.4251\/wjgo.v17.i11.109375","volume":"15","author":"Z Wang","year":"2025","unstructured":"Wang Z, Cheng JW, Yu KY (2025) Short-term and long-term effects of sevoflurane inhalation vs propofol total intravenous anesthesia in gastrectomy for gastric cancer. World J Gastrointest Oncol Nov 15(11):109375. https:\/\/doi.org\/10.4251\/wjgo.v17.i11.109375","journal-title":"World J Gastrointest Oncol Nov"},{"issue":"1","key":"4329_CR28","doi-asserted-by":"publisher","first-page":"101850","DOI":"10.1016\/j.gassur.2024.10.005","volume":"29","author":"DJ Szor","year":"2025","unstructured":"Szor DJ, Pereira MA, Ramos MFKP et al (2025) Peritoneal recurrence in gastric cancer after curative gastrectomy: risk factors and predictive score model. J Gastrointest Surg Jan 29(1):101850. https:\/\/doi.org\/10.1016\/j.gassur.2024.10.005","journal-title":"J Gastrointest Surg Jan"},{"issue":"5","key":"4329_CR29","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1245\/s10434-024-14997-4","volume":"21","author":"MP van Nieuw Amerongen","year":"2024","unstructured":"van Nieuw Amerongen MP, de Grooth HJ, Veerman GL et al (2024) Prediction of morbidity and mortality after esophagectomy: a systematic review. Ann Surg Oncol Feb 21(5):3459\u20133470. https:\/\/doi.org\/10.1245\/s10434-024-14997-4","journal-title":"Ann Surg Oncol Feb"},{"issue":"24","key":"4329_CR30","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.3390\/jcm12247622","volume":"11","author":"J Edmondson","year":"2023","unstructured":"Edmondson J, Hunter J, Bakis G et al (2023) Understanding post-esophagectomy complications and their management: the early complications. J Clin Med Dec 11(24):7622. https:\/\/doi.org\/10.3390\/jcm12247622","journal-title":"J Clin Med Dec"},{"issue":"6","key":"4329_CR31","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/SLA.0000000000003210","volume":"271","author":"LR van der Werf","year":"2020","unstructured":"van der Werf LR, Busweiler LAD, van Sandick JW et al (2020) Reporting national outcomes after esophagectomy and gastrectomy according to the Esophageal Complications Consensus Group (ECCG). Ann Surg Jun 271(6):1095\u20131101. https:\/\/doi.org\/10.1097\/SLA.0000000000003210","journal-title":"Ann Surg Jun"},{"issue":"4","key":"4329_CR32","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1053\/j.jvca.2020.10.036","volume":"35","author":"J Beverstock","year":"2021","unstructured":"Beverstock J, Park T, Alston RP et al (2021) A Comparison of Volatile Anesthesia and Total Intravenous Anesthesia (TIVA) Effects on Outcome From Cardiac Surgery: A Systematic Review and Meta-Analysis. J Cardiothorac Vasc Anesth Apr 35(4):1096\u20131105. https:\/\/doi.org\/10.1053\/j.jvca.2020.10.036","journal-title":"J Cardiothorac Vasc Anesth Apr"},{"key":"4329_CR33","doi-asserted-by":"crossref","unstructured":"JA S (2006) Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 97:127\u2013136","DOI":"10.1093\/bja\/ael149"},{"issue":"1","key":"4329_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/2045-9912-2-22","volume":"2012\/08\/28","author":"NR Van Allen","year":"2012","unstructured":"Van Allen NR, Krafft PR, Leitzke AS, Applegate RL, Tang J, Zhang JH (2012) The role of Volatile Anesthetics in Cardioprotection: a systematic review. Med Gas Res 2012\/08\/28(1):22. https:\/\/doi.org\/10.1186\/2045-9912-2-22","journal-title":"Med Gas Res"},{"issue":"9","key":"4329_CR35","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00134-016-4429-x","volume":"42","author":"B O\u2019Gara","year":"2016","unstructured":"O\u2019Gara B, Talmor D (2016) Lung protective properties of the volatile anesthetics. Intensive Care Med Sep 42(9):1487\u20131489. https:\/\/doi.org\/10.1007\/s00134-016-4429-x","journal-title":"Intensive Care Med Sep"},{"issue":"3","key":"4329_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/bja\/aem184","volume":"99","author":"T Schilling","year":"2007","unstructured":"Schilling T, Kozian A, Kretzschmar M et al (2007) Effects of propofol and desflurane anaesthesia on the alveolar inflammatory response to one-lung ventilation. Br J Anaesth 99(3):368\u2013375","journal-title":"Br J Anaesth"},{"issue":"6","key":"4329_CR37","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1097\/aln.0000000000001120","volume":"124","author":"C Uhlig","year":"2016","unstructured":"Uhlig C, Bluth T, Schwarz K et al (2016) Effects of Volatile Anesthetics on Mortality and Postoperative Pulmonary and Other Complications in Patients Undergoing Surgery: A Systematic Review and Meta-analysis. Anesthesiology 124(6):1230\u20131245. https:\/\/doi.org\/10.1097\/aln.0000000000001120","journal-title":"Anesthesiology"},{"key":"4329_CR38","doi-asserted-by":"publisher","first-page":"116916","DOI":"10.1016\/j.lfs.2019.116916","volume":"239","author":"X Yang","year":"2019","unstructured":"Yang X, Zheng Y-t, Rong W (2019) Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras\/Raf\/MEK\/ERK signaling. Life Sci 239:116916","journal-title":"Life Sci"},{"issue":"6","key":"4329_CR39","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/aln.0000000000003129","volume":"132","author":"W Zhang","year":"2020","unstructured":"Zhang W, Sheng B, Chen S et al (2020) Sevoflurane Enhances Proliferation, Metastatic Potential of Cervical Cancer Cells via the Histone Deacetylase 6 Modulation In Vitro. Anesthesiology Jun 132(6):1469\u20131481. https:\/\/doi.org\/10.1097\/aln.0000000000003129","journal-title":"Anesthesiology Jun"},{"issue":"4","key":"4329_CR40","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1213\/ANE.0000000000004778","volume":"131","author":"X Zheng","year":"2020","unstructured":"Zheng X, Dong L, Zhao S et al (2020) Propofol affects non\u2013small-cell lung cancer cell biology by regulating the miR-21\/PTEN\/AKT pathway in vitro and in vivo. Anesth Analgesia 131(4):1270\u20131280","journal-title":"Anesth Analgesia"},{"issue":"3","key":"4329_CR41","first-page":"290","volume":"45","author":"B Liang","year":"2020","unstructured":"Liang B, Dong T (2020) Effects of propofol on invasion and migration of colon cancer cells and JAK2\/STAT3 signaling pathway. Zhong nan da xue xue bao Yi xue ban= J Cent South Univ Med Sci 45(3):290\u2013296","journal-title":"Zhong nan da xue xue bao Yi xue ban= J Cent South Univ Med Sci"},{"issue":"10211","key":"4329_CR42","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(19)32313-X","volume":"394","author":"DI Sessler","year":"2019","unstructured":"Sessler DI, Pei L, Huang Y et al (2019) Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial. lancet 394(10211):1807\u20131815","journal-title":"lancet"},{"issue":"2","key":"4329_CR43","doi-asserted-by":"publisher","first-page":"e54094","DOI":"10.7759\/cureus.54094","volume":"16","author":"FA Kamal","year":"2024","unstructured":"Kamal FA, Fernet LY, Da Silva NK et al (2024) Comparing Perioperative Outcomes of Total Intravenous Anesthesia (TIVA) With Volatile Anesthesia in Patients With Obesity: A Systematic Review. Cureus Feb 16(2):e54094. https:\/\/doi.org\/10.7759\/cureus.54094","journal-title":"Cureus Feb"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-026-04329-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04329-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04329-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:03:07Z","timestamp":1791486187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-026-04329-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4329"],"URL":"https:\/\/doi.org\/10.1007\/s00423-026-04329-3","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"20 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"268"}}